NHMRC Medicines Intelligence Centre of Research Excellence

In 2019, quality use of medicines and medicines safety became Australia's 10th National Health Priority due to the significant health and economic impacts from their misuse and overuse. In November 2020, the Medicines Intelligence Centre of Research Excellence (MI-CRE) was established to accelerate the generation and translation of 'real-world' evidence on prescribed medicines in Australia, to enhance the quality use of medicines and reduce medicine-related harm. Professor Sallie Pearson leads the national collaboration of 20 investigators and their research teams based across eight Australian universities, including UNSW Sydney, University of South Australia, University of Sydney, and University of Western Australia. MI-CRE uses population-based linked data and sophisticated methods to study the use of medicines in routine clinical practice and their benefits, safety, and costs. Through engagement with policymakers, MI-CRE is developing and scaling sustainable approaches for timely evidence generation and research translation. Additionally, MI-CRE provides innovative training to foster the growth of the next generation of research leaders. Funding: National Health and Medical Research Council Centre of Research Excellence grant 2020-2024 APP1196900 Contact: mi-cre@unsw.edu.au Dr Natasha Donnolley MI-CRE Program and Communications Manager Professor Sallie Pearson MI-CRE Director and Professor of Health Systems, UNSW